Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva

被引:31
作者
Shugars, DC [1 ]
Slade, GD
Patton, LL
Fiscus, SA
机构
[1] Univ N Carolina, Sch Dent, Dept Dent Ecol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS | 2000年 / 89卷 / 04期
关键词
D O I
10.1016/S1079-2104(00)70124-7
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective. The purpose of this investigation was to quantify human immunodeficiency virus type-1 (HIV-1) RNA in saliva and plasma and identify factors associated with increased salivary viral load. Study design. Forty HIV-1-seropositive adults underwent oral examinations to assess mucosal and periodontal health. Whole saliva was evaluated for HIV-1 RNA titer and occult blood. Plasma viral load, CD4 cell count, HIV-1 staging, and antiretroviral therapy data were obtained from medical records. Associations between salivary titers and oral/systemic parameters were analyzed by means of t tests, Wilcoxon signed rank tests, Pearson's correlation coefficient and analysis of covariance. Results, Forty-two percent of the subjects had detectable salivary HIV-1 RNA. Oral titers were highly correlated with plasma viral levels (r = 0.51, P < .01). HIV-associated periodontal disease (in particular, linear gingival erythema), severe gingival inflammation, and absence of antiretroviral therapy were associated with high salivary titers (P < .01). Conclusions. Substantial quantities of HIV-1 can be shed in the oral cavity, particularly when inflammatory conditions are present. Salivary titer may be a useful indicator of systemic viral burden.
引用
收藏
页码:432 / 440
页数:9
相关论文
共 45 条
[1]   Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes [J].
Baron, S ;
Poast, J ;
Cloyd, MW .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (03) :303-310
[2]  
Barr C E, 1996, Oral Dis, V2, P198
[3]   Periodontal disease and cardiovascular disease [J].
Beck, J ;
Garcia, R ;
Heiss, G ;
Vokonas, PS ;
Offenbacher, S .
JOURNAL OF PERIODONTOLOGY, 1996, 67 (10) :1123-1137
[4]  
Beck J D, 1998, J Dent Educ, V62, P859
[5]   RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].
BOOM, R ;
SOL, CJA ;
SALIMANS, MMM ;
JANSEN, CL ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503
[6]   Reduction of concentration of HIV-1, in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1 [J].
Cohen, MS ;
Hoffman, IF ;
Royce, RA ;
Kazembe, P ;
Dyer, JR ;
Daly, CC ;
Zimba, D ;
Vernazza, PL ;
Maida, M ;
Fiscus, SA ;
Eron, JJ ;
Nkata, E ;
Kachenje, E ;
Banda, T ;
Mughogho, G ;
Koller, C ;
Schock, J ;
Chakraborty, H ;
Dallabetta, G ;
Gilliam, B .
LANCET, 1997, 349 (9069) :1868-1873
[7]   Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood [J].
Coombs, RW ;
Speck, CE ;
Hughes, JP ;
Lee, W ;
Sampoleo, R ;
Ross, SO ;
Dragavon, J ;
Peterson, G ;
Hooton, TM ;
Collier, AC ;
Corey, L ;
Koutsky, L ;
Krieger, JN .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (02) :320-330
[8]   Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: Relationship to HIV-1-specific inhibitory factors in human saliva [J].
Crombie, R ;
Silverstein, RL ;
MacLow, C ;
Pearce, SFA ;
Nachman, RL ;
Laurence, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) :25-35
[9]  
Duggan C., 1992, MMWR-MORBID MORTAL W, V41, P1
[10]   Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: Comparison of NASBA(TM) with Amplicor(TM) reverse transcription-PCR amplification and correlation with quantitative culture [J].
Dyer, JR ;
Gilliam, BL ;
Eron, JJ ;
Grosso, L ;
Cohen, MS ;
Fiscus, SA .
JOURNAL OF VIROLOGICAL METHODS, 1996, 60 (02) :161-170